These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 506207)

  • 1. [Differences in the properties of the interferons produced by the leukocytes of healthy persons and of cancer and leukemia patients].
    Pokidysheva LN; Marchenko VI; Zubanova NA; Moĭsiadi SA; Fedorova IuB
    Vopr Virusol; 1979; (5):532-5. PubMed ID: 506207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reasons for lowered resistance to Krebs 2 ascitic carcinoma in mice in a state of hyporeactivity (tolerance) to a viral interferon inducer].
    Marchenko VI; Pokidysheva LN; Zubanova NA; Voronina FV
    Vopr Virusol; 1976; (2):176-9. PubMed ID: 936575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon and antibody production in inbred mice infected with the Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(1):23-7. PubMed ID: 4335323
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of hyporeactivity (tolerance) to a viral interferon inducer on the transplantation of Krebs 2 ascitic carcinoma cells in mice].
    Marchenko VI; Pokidysheva LN
    Vopr Virusol; 1974; (4):396-400. PubMed ID: 4439850
    [No Abstract]   [Full Text] [Related]  

  • 5. [Differences in the antiviral and antioncogenic action of interferons produced in murine peritoneal cells and in Krebs-2 ascitic carcinoma cells].
    Marchenko VI; Pokidysheva LN; Malinovskaia VV; Aliab'eva TI; Khesin IaE
    Vopr Virusol; 1977; (3):344-8. PubMed ID: 198969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon production by mouse leukocytes in vitro and in vivo.
    GLASGOW LA; HABEL K
    J Exp Med; 1963 Jan; 117(1):149-60. PubMed ID: 13948365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of interferon treatment on the tumour-specific antibody response of BALB-c mice infected with Rauscher virus.
    Tóth FD; Váczi L; Berencsi C
    Acta Microbiol Acad Sci Hung; 1971; 18(2):109-12. PubMed ID: 4337368
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytokine production by human leukocytes with different expressions of natural antiviral immunity and the effect of antibodies against interferons and TNF-alpha.
    Orzechowska B; Antoszków Z; Siemieniec I; Lorenc M; Jatczak B; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2007; 55(2):111-7. PubMed ID: 17417691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interferon production in vitro (by leukocytes) in response to arbovirus infections].
    Fomina AN; Shubladze AK
    Vopr Virusol; 1975; (3):302-5. PubMed ID: 1162950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of human leukocyte and fibroblast interferons on normal and chronic myelogenous leukemic granulocytic progenitor cells.
    Williams CK; Svet-Moldavskaya I; Vilcek J; Ohnuma T; Holland JF
    Oncology; 1981; 38(6):356-60. PubMed ID: 6170921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon production in leukaemia.
    Chisholm M; Cartwright T
    Br J Haematol; 1978 Sep; 40(1):43-50. PubMed ID: 280360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Swine blood leukocytes--new source of production of inferferon active in human cells].
    Solov'ev VD; Ogarkov VI; Marchenko VI; Monastyreva LA; Pokidysheva LN
    Vopr Virusol; 1980; (5):521-5. PubMed ID: 6159734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon and host resistance to Rauscher virus-induced leukemia.
    Glasgow LA; Friedman SB
    J Virol; 1969 Feb; 3(2):99-105. PubMed ID: 5774143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine leukemia: depressed response to interferon induction correlated with a serum hyporeactive factor.
    Stringfellow DA
    Infect Immun; 1976 Feb; 13(2):392-8. PubMed ID: 177366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of combined administration of neuraminidase and interferon in mice with Rauscher leukemia].
    Kobrinskiĭ GD; Barinskiĭ IF; Efimova IV; Eremian LK
    Biull Eksp Biol Med; 1982 Jan; 93(1):62-4. PubMed ID: 6175365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interferon production by bovine tissues: effects of hydrocortisone.
    Fulton RW; Rosenquist BD
    Am J Vet Res; 1976 Dec; 37(12):1493-5. PubMed ID: 187092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro assessment of cellular immunity to Rauscher leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Sep; 111(3):657-60. PubMed ID: 4741293
    [No Abstract]   [Full Text] [Related]  

  • 18. Enchancement of leukemogenesis in mice after prolonged administration of anti-interferon or normal rabbit globulin.
    Inglot AD; Chudzio T
    Arch Virol; 1977; 55(1-2):67-75. PubMed ID: 921545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumor necrosis factor in the immunity of leukocytes.
    Orzechowska B; Antoszków Z; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):51-60. PubMed ID: 12691304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of interferon-induced viral resistance from human leukocytes to other cell types.
    Blalock JE; Weigent DA; Langford MP; Stanton GJ
    Infect Immun; 1980 Aug; 29(2):356-60. PubMed ID: 6163708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.